// App-Quantinova.ai

WP254 : The Contribution of Serpinf2 to Tissue Plasminogen Activator Therapy for Stroke: Effects on Neuronal Cell Death, Brain Swelling, Breakdown of the Blood Brain Barrier and Mortality

Researchers

Presenter

  • Aiilyan Houng

Principal Investigators

  • Guy Reed

Medical Centers

  • University of Tennessee, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • Matrix metallopeptidase 9

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim